FDA Deluged With Feedback On Off-Label Policies
The U.S. Food and Drug Administration is getting flooded with praise and criticism from drugmakers, device makers, consumer advocates and trial lawyers regarding recent policy statements about off-label promotion, newly released...To view the full article, register now.
Already a subscriber? Click here to view full article